PGNY Progyny, Inc.
FY2025 10-K
Progyny, Inc. (PGNY) filed its fiscal year 2025 10-K annual report with the SEC on Feb 27, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2025 10-K
Business Overview
- • Core business model: Fertility benefits solution providing proprietary Smart Cycle treatment bundles with care management and pharmacy benefits add-on
- • New emphasis on expanded women's health and family building services including pregnancy/postpartum and menopause, strategic investments but not material revenue yet
Management Discussion & Analysis
- • No revenue or profitability data disclosed in this section, focus on risks to network and operations
- • Key segment: Center of Excellence fertility network, risk of losing providers or higher costs impacting margins
Risk Factors
- • No specific, timely regulatory or legal risk identified
- • Economic impacts from potential changes in healthcare funding affect Progyny's fertility benefits offerings, no quantification provided
Get deeper insights on Progyny, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.